RE:RE:Unbelievable....$20 plus shareprice leaves a lot of investors on the side lines and all the negative news isn't helping either. There is an abundance of underfinanced potpreneurs that are going to tank and the most likely companies still aren't showing black ink. The big guys are positioning for supremacy but even that takes a lot of money and venture capital for pot companies is hugely expensive if available at all. The US MSOs don't have access to banking or brokering yet and jmho, but they are the most likely to succeed because they are already in the US doing legal CBD, Medicinal Pot and Rec for adults where allowed. Most have ipo'd on the CSE and some on the TSE. Canopy has Acreage locked up for US legalization or legal banking availability could be a trigger. Acreage is mostly forgotten about by investors and it shows in their shareprice but it is amongst the biggest MSO in the US and Canopy knows they need the US and what Acreage brings to the party to maintain a leadership role as this unfolds. The US is the holdout and it is becoming a high profile carrot for the next US leadership. When the US gets it together and paves the way for the new, safer vice of cannabinoids, there won't be enough shares for the demand from US investors who are sitting their with fistfulls of cash, wanting to be invested in the greenrush. Investment comanies and bankers/brokers are sitting on the sidelines too, and they are going to want to be with well financed potpreneurs like Canopy. It's "all-in" time for the biggies and exit time for junior pot hopefuls. Canopy has the future covered with Acreage, already paid for and just a share swap to complete the deal. glta and dyodd